Search Results 321-330 of 13859 for Polyunsaturated%2Bfat

  1. Shrimp and grits - Mayo Clinic

    Total fat 6 g; Saturated fat 2 g; Trans fat Trace; Monounsaturated fat 3 g. Polyunsaturated fat 1 g; Cholesterol 79 mg; Sodium 470 mg; Potassium 165 mg; Calcium ...

  2. Fatty liver disease (MASLD) - Doctors and departments - Mayo Clinic

    This liver condition is becoming more common in the Western world. Find out how to treat and prevent this potentially dangerous liver disease.

  3. Nutrition and healthy eating Nutritional supplements - Mayo Clinic

    See also · ​ Vitamins and supplements for fatty liver disease (MASLD) · 10 great health foods · Add antioxidants to your diet · Alcohol use: Weighing risks and ...

  4. Nutrition and healthy eating Nutrition basics - Mayo Clinic

    Gluten sensitivity and psoriasis: What's the connection? Grass-fed beef · High-protein diets · How to track saturated fat · Intermittent fasting · Is caffeine ...

  5. The Mayo Clinic Diet: A weight-loss program for life

    Have low-fat frozen yogurt or dark chocolate on Monday, and then hold off on ... fats — can further reduce your risk of certain health conditions. The ...

  6. Gastroenterology and Hepatology - Clinical trials

    Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. It is ...

  7. French country chicken with mushroom sauce - Mayo Clinic

    Polyunsaturated fat 1 g; Total sugars 2 g; Magnesium 43 mg; Vitamin D 3 IU; Iron 1 mg. Mayo Clinic Healthy Weight Pyramid Servings. Vegetables 1; Protein and ...

  8. Spicy ground turkey tacos - Mayo Clinic

    Monounsaturated fat 1.5 g; Saturated fat 5 g; Trans fat Trace; Sodium 840 mg. Added sugars 0 g; Total sugars 13 g; Polyunsaturated fat 0.5 g; Cholesterol 55 mg ...

  9. A Study of the Use of a New Drug in People with Non-Alcoholic Steatohepatitis (NASH) or Non-Alcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

    The purpose of this study is to assess a new drug to decrease liver fat in subjects with Non-Alcoholic Steatohepatitis or Non-Alcoholic Fatty Liver Disease.

  10. Phase 2a, Dose-ranging Study With PF-05221304 In Nonalcoholic Fatty Liver Disease (NAFLD) - Mayo Clinic

    Phase 2a, Dose-ranging Study With PF-05221304 In Nonalcoholic Fatty Liver Disease (NAFLD) · Overview · Participation eligibility · Participating Mayo Clinic ...